TILT Holdings (TLLTF) Other Accumulated Expenses (2024 - 2025)

TILT Holdings (TLLTF) reported Other Accumulated Expenses of $1.9 million for Q2 2025, up 57.07% quarter-over-quarter from $1.2 million in Q1 2025.

TILT Holdings (TLLTF) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

TILT Holdings has reported Other Accumulated Expenses for 2 years, with the latest figure at $1.9 million in Q2 2025.

For the quarter ending Q2 2025, Other Accumulated Expenses changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Jun 2025 stood at $1.9 million (changed N/A YoY), and the FY2024 full-year result was $834000.0, changed N/A from the prior year.
Other Accumulated Expenses for Q2 2025 stood at $1.9 million, up from $1.2 million in the prior quarter.
The five-year high for Other Accumulated Expenses was $1.9 million in Q2 2025, with the low at $834000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	TILT Holdings	-	-	1.82 Mn

Download Data